Please select the option that best describes you:
Topics:
Breast Cancer • Radiation Oncology
Would you treat a patient with an early stage favorable breast cancer who has synchronous advanced (or metastatic) NSCLC?
What factors would help you make your decision? (Age, genetics of lung or breast cancer, triple negative, LVSI, T2, etc?)
Answer from: Radiation Oncologist at Academic Institution
Unfortunately, despite recent advances, the survival for locally advanced or metastatic NSCLC remains poor. As someone who treats both lung and breast, I would have a multi-disciplinary discussion with the teams regarding any added benefit of treating the early stage breast cancer. I think the facto...
Sign in or Register to read more